These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 949176)

  • 21. Mecillinam (FL 1060), a 6beta-amidinopenicillanic acid derivative: bactericidal action and synergy in vitro.
    Tybring L; Melchior NH
    Antimicrob Agents Chemother; 1975 Sep; 8(3):271-6. PubMed ID: 170856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amoxicillin: in vitro susceptibility of "blood culture strains" of gram-negative bacilli and comparisons with penicillin G ampicillin, and carbenicillin.
    Finland M; McGowan JE; Garner C; Wilcox C
    J Infect Dis; 1974 Jun; 129(0):suppl:S132-8. PubMed ID: 4210005
    [No Abstract]   [Full Text] [Related]  

  • 23. Synergy of mecillinam (FL1060) with penicillins and cephalosporins against Proteus and Klebsiella, with observations on combinations with other antibiotics and against other bacterial species.
    Baltimore RS; Klein JO; Wilcox C; Finland M
    Antimicrob Agents Chemother; 1976 Apr; 9(4):701-5. PubMed ID: 1267442
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro activity of AVE1330A, an innovative broad-spectrum non-beta-lactam beta-lactamase inhibitor.
    Bonnefoy A; Dupuis-Hamelin C; Steier V; Delachaume C; Seys C; Stachyra T; Fairley M; Guitton M; Lampilas M
    J Antimicrob Chemother; 2004 Aug; 54(2):410-7. PubMed ID: 15254025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
    Masuyoshi S; Arai S; Miyamoto M; Mitsuhashi S
    Antimicrob Agents Chemother; 1980 Jul; 18(1):1-8. PubMed ID: 6251749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of beta-lactamase and salt on mecillinam susceptibility of enterobacterial strains.
    Bongaerts GP; Bruggeman-Ogle KM
    Antimicrob Agents Chemother; 1980 Nov; 18(5):680-6. PubMed ID: 6255865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jan; 21(1):11-8. PubMed ID: 6805421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.
    Rahal JJ; Simberkoff MS; Kagan K; Moldover NH
    Antimicrob Agents Chemother; 1976 Apr; 9(4):595-9. PubMed ID: 817661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic activity of mecillinam in combination with the beta-lactamase inhibitors clavulanic acid and sulbactam.
    Neu HC
    Antimicrob Agents Chemother; 1982 Sep; 22(3):518-9. PubMed ID: 6291454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction/inhibition of chromosomal beta-lactamases by beta-lactamase inhibitors.
    Moosdeen F; Keeble J; Williams JD
    Rev Infect Dis; 1986; 8 Suppl 5():S562-8. PubMed ID: 3026004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro studies of a new semisynthetic penicillin, 6-(d-alpha-sulfoaminophenylacetamido)-penicillanic acid.
    Bodey GP; Stewart D
    Appl Microbiol; 1969 Jul; 18(1):76-9. PubMed ID: 4896105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
    Hall WH; Opfer BJ; Gerding DN
    Antimicrob Agents Chemother; 1980 Feb; 17(2):273-9. PubMed ID: 6247970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mecillinam activity compared to ampicillin, trimethoprim/sulfamethoxazole, ciprofloxacin and nitrofurantoin against urinary tract isolates of gram-negative bacilli.
    Zhanel GG; Karlowsky JA; Schwartz B; Jensen SB; Hoban DJ
    Chemotherapy; 1998; 44(6):391-6. PubMed ID: 9755298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial activity of apalcillin (PC-904) against gram-negative bacilli, especially ampicillin-, carbenicillin-, and gentamicin-resistant clinical isolates.
    Noguchi H; Kubo M; Kurashige S; Mitsuhashi S
    Antimicrob Agents Chemother; 1978 May; 13(5):745-52. PubMed ID: 248269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azlocillin: in vitro studies of a new semisynthetic penicillin.
    Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GR-20263: a new aminothiazolyl cephalosporin with high activity against Pseudomonas and Enterobacteriaceae.
    Verbist L; Verhaegen J
    Antimicrob Agents Chemother; 1980 May; 17(5):807-12. PubMed ID: 6994640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of YTR 830.
    Jacobs MR; Aronoff SC; Appelbaum PC; Yamabe S
    J Chemother; 1989 Jun; 1(3):151-4. PubMed ID: 2552029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temocillin: in vitro activity against 734 selected clinical isolates, including beta-lactamase-producing strains.
    Fuchs PC; Barry AL; Jones RN; Thornsberry C
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):55-63. PubMed ID: 6443203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M; Garner C; Wilcox C; Sabath LD
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate.
    Fass RJ; Prior RB
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1268-74. PubMed ID: 2552904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.